Zoetis (ZTS)

Zoetis Inc. (NYSEZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2024 financial results and respond to questions from financial analysts during the call.

The Board of Directors of Zoetis Inc. (NYSEZTS) has declared a dividend of $0.50 per share for the first quarter of 2025, an increase of 16% from the quarterly dividend rate paid in 2024. The dividend will be paid on Tuesday, March 4, 2025, to all holders of record of the Company’s common stock as of the close of business on Tuesday, January 21, 2025.

Zoetis Inc. (NYSEZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 11:30 a.m. ET.

Zoetis Inc. (NYSEZTS) today announced the appointment of Jamie Brannan to a newly created role of Chief Commercial Officer, overseeing all commercial markets across the globe for the world’s leading animal health company. In this new role, Mr. Brannan will lead an evolved commercial organizational structure that will accelerate the company’s long-term growth strategy across key markets, drive greater global commercial collaboration and unlock future growth opportunities.

Zoetis Inc. (NYSEZTS) will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 3:00 p.m. GMT.

Zoetis Inc. (NYSEZTS) today reported its financial results for the third quarter of 2024 and raised its full year 2024 guidance for revenue and adjusted EPS.

The Board of Directors of Zoetis Inc. (NYSEZTS) has declared a dividend of $0.432 per share for the fourth quarter of 2024. The dividend will be paid on Tuesday, December 3, 2024, to all holders of record of the Company’s common stock as of the close of business on Thursday, October 31, 2024.

Zoetis and Danone recently announced a joint business development plan to drive sustainable practices on today’s dairy farms through the power of genetics for healthier cows. Combining Danone’s commitment to environmental stewardship with Zoetis’ expertise in animal genetics, the partnership aims to innovate the dairy industry’s approach to breeding for sustainability.

Zoetis Inc. (NYSEZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Monday, November 4, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2024 financial results and respond to questions from financial analysts during the call.

Zoetis Inc. (NYSEZTS) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 1:05 p.m. ET.

ZTS stock and CHWY stock have different investment cases, but here's what investors may want to consider before buying either of these pet stocks

Zoetis Inc. (NYSEZTS) today reported its financial results for the second quarter of 2024 and raised its guidance for full year 2024.

Zoetis Inc. (NYSEZTS) today announced that its Board of Directors has approved a multi-year $6 billion share repurchase program as part of its capital allocation plans. The demand for Zoetis’ innovative and market-leading portfolio has enabled the company to execute its disciplined capital allocation strategy by reinvesting in growth opportunities and returning capital to shareholders, while delivering long-term value.

Zoetis Inc. (NYSEZTS) will now host its second-quarter 2024 financial results webcast and conference call at 8:00 a.m. (ET) on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements.

Zoetis Inc. (NYSEZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, August 6, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2024 financial results and respond to questions from financial analysts during the call.

As animals and communities continue to face mounting challenges from natural disasters, Zoetis Inc. and the Zoetis Foundation are committed to supporting animal health and community resilience. The Zoetis Foundation brings this commitment to life through grant support to the American Red Cross, which will help provide necessary emergency preparedness and relief to families and communities impacted by disasters. Zoetis Inc. partners with American Humane to increase disaster preparedness and help support the well-being of animals during emergencies.

Zoetis Inc. today published its 2023 Sustainability Report “Advancing Sustainability in Animal Health for a Better Future,” to highlight the company’s progress in achieving its Driven to Care long-term sustainability aspirations and provide continued disclosure on environmental, social and governance (ESG) topics. The report shares Zoetis’ actions to meet aspirations across three pillars: Communities, Animals and Planet. Included in the report is the company’s Sustainability Accounting Standards Board (SASB) and ESG Index, which provides relevant performance indicators, including those identified by SASB for the healthcare – biotechnology and pharmaceuticals industry. This Index also includes Zoetis’ commitment to disclosing progress aligned with the Taskforce on Climate-related Financial Disclosure (TCFD), plus a link to the 2023 CDP Climate Change Questionnaire.

The Board of Directors of Zoetis Inc. (NYSEZTS) has declared a dividend of $0.432 per share for the third quarter of 2024. The dividend will be paid on Wednesday, September 4, 2024, to all holders of record of the Company’s common stock as of the close of business on Thursday, July 18, 2024.

Zoetis Inc. (NYSEZTS) will participate in the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:40 p.m. CT.

Zoetis Inc. (NYSEZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:05 p.m. ET.

Zoetis Inc. (NYSEZTS) has been named to Fair360’s Top 50 Companies list for the first time, underscoring the company’s progress and sustained commitment to advancing Diversity, Equity and Inclusion (DE&I). Zoetis is the only animal health company included in this year’s Top 50 rankings.

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zoetis Inc. (NYSEZTS), and Morgan Stanley NYSE: MSNYSEMS)

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

WHY: NEW YORK, NY - (NewMediaWire) - May 05, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zoetis Inc. (NYSEZTS) resulting from allegations that Zoetis may have issued materially misleading business information to the investing public.

NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) --